← Evidence map

ArticleFrontiers in pharmacology2022

Optimal Regimens and Clinical Breakpoint of Avilamycin Against

Anxiong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 35281904